Schizophrenia

Showing NaN - NaN of 145

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Schizophrenia Trial in New York (Overnight polysomnography examinations)

Recruiting
  • Schizophrenia
  • Overnight polysomnography examinations
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Apr 4, 2022

Schizophrenia, Schizoaffective Disorder Trial in United States (Clozapine, treatment as usual)

Recruiting
  • Schizophrenia
  • Schizoaffective Disorder
  • Los Angeles, California
  • +6 more
Mar 25, 2022

Long Acting Injectable Medications in Schizophrenia

Active, not recruiting
  • Schizophrenia
    • Tucson, Arizona
    • +56 more
    Feb 10, 2022

    Dysmyelination in Cognitive Impairment of Psychotic Spectrum

    Recruiting
    • Schizophrenia
    • Bipolar Disorder
    • Cognitive Function Assessments
    • New York, New York
      New York University School of Medicine
    Feb 10, 2022

    Schizophrenia Trial in Worldwide (TV-46000, Placebo)

    Completed
    • Schizophrenia
    • Phoenix, Arizona
    • +89 more
    Feb 5, 2022

    Psychosis, Schizophrenia, Schizoaffective Disorder Trial in New York (ceftriaxone, Normal Saline)

    Terminated
    • Psychosis
    • +2 more
    • New York, New York
      NYS Psychiatric Institute
    Dec 14, 2021

    Schizophrenia Trial in Worldwide (Luvadaxistat, Placebo)

    Completed
    • Schizophrenia
    • Garden Grove, California
    • +53 more
    Dec 7, 2021

    Psychosis, Schizoaffective Disorder, Schizophrenia Trial in New York (OnTrack>TheGame (OTG), Recovery Videos (RV))

    Completed
    • Psychosis
    • +2 more
    • OnTrack>TheGame (OTG)
    • Recovery Videos (RV)
    • New York, New York
      New York State Psychiatric Institute
    Nov 24, 2021

    Schizophrenia Trial in New York (ITI-007)

    Terminated
    • Schizophrenia
    • New York, New York
      New York State Psychiatric Institute
    Nov 2, 2021

    Schizophrenia, Alcohol Use Disorder Trial in Bulgaria, Poland, United States (Samidorphan + olanzapine (ALKS 3831), Placebo +

    Completed
    • Schizophrenia
    • Alcohol Use Disorder
    • Samidorphan + olanzapine (ALKS 3831)
    • Placebo + olanzapine
    • Little Rock, Arkansas
    • +70 more
    Sep 14, 2021

    Schizophrenia Trial in Worldwide (LY2140023, Placebo, Standard of Care)

    Completed
    • Schizophrenia
    • Garden Grove, California
    • +8 more
    Aug 25, 2021

    Schizophrenia Trial in United States (Abilify MyCite®)

    Terminated
    • Schizophrenia
    • Abilify MyCite®
    • Phoenix, Arizona
    • +67 more
    Aug 10, 2021

    Schizophrenia, Schizoaffective Disorder Trial in New York (Active Transcranial direct current stimulation (tDCS), Sham

    Completed
    • Schizophrenia
    • Schizoaffective Disorder
    • Active Transcranial direct current stimulation (tDCS)
    • +3 more
    • New York, New York
      New York State Psychiatric Institute
    Jun 16, 2021

    Schizophrenia Trial in United States (ABT-126, Placebo)

    Completed
    • Schizophrenia
    • Chino, California
    • +19 more
    Jul 2, 2021

    Potential Biomarkers in Schizophrenia and Healthy Volunteer

    Completed
    • Schizophrenia
    • Event-Related Potentials (ERP) and Electroencephalogram (EEG) testing with the COGNISION® System
    • Garden Grove, California
    • +3 more
    Feb 22, 2021

    Schizophrenia Trial in United States (Basmisanil, Placebo)

    Completed
    • Schizophrenia
    • Little Rock, Arkansas
    • +36 more
    Jan 21, 2021

    Biomarkers in First Episode Schizophrenia

    Completed
    • Schizophrenia
    • +2 more
      • New York, New York
        Bellevue Hospital
      Jan 11, 2021

      Schizophrenia Trial in United States (AQW051, Placebo)

      Completed
      • Schizophrenia
      • Los Angeles, California
      • +6 more
      Dec 16, 2020

      Schizophrenia Trial in Worldwide (Lu AF35700)

      Completed
      • Schizophrenia
      • Lu AF35700
      • Bellflower, California
      • +101 more
      Sep 30, 2020

      Schizophrenia Trial in New York (Cognitive remediation therapy)

      Completed
      • Schizophrenia
      • Cognitive remediation therapy
      • New York, New York
        Manhattan Psychiatric Center
      Oct 2, 2020

      Schizophrenia Trial in United States (AVP-786, Placebo)

      Completed
      • Schizophrenia
      • Cerritos, California
      • +16 more
      Aug 27, 2020

      Schizophrenia, Schizoaffective Disorder Trial in Bronx, Brooklyn, New York (Cognitive remediation)

      Completed
      • Schizophrenia
      • Schizoaffective Disorder
      • Cognitive remediation
      • Bronx, New York
      • +4 more
      Sep 11, 2020

      Imaging Dopamine D2 Agonist Binding Sites in Schizophrenia

      Withdrawn
      • Schizophrenia
      • NPA radiotracer
      • +2 more
      • New York, New York
        NYU Langone Health
      May 27, 2020